Goodwin Procter advised Bicara Therapeutics on the deal. Bicara Therapeutics announced the completion of its oversubscribed $108 million Series B financing to advance the company’s lead program...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Rapport Therapeutics, Inc. on the deal. Rapport Therapeutics, Inc. announced its launch with a $100 million Series A financing from Third Rock Ventures, ARCH...
You must be a Standard 1 Year member to access this content.
Goodwin advised Cionix GmbH on the deal. Cionix GmbH (“cionix”) announced the sale of its hosting business to dogado GmbH (“dogado”). Dogado is a leading provider of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Jefferies LLC as exclusive placement agent on the deal. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced that it has executed financing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Terreno Realty Corporation on the deal. Terreno Realty Corporation (NYSE: TRNO) announced its underwritten public offering of 5,750,000 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Polychain Capital on the deal. Polychain Capital announced its lead investment in SPACE ID’s $10 million strategic funding round, with dao5 also participating. Polychain,...
You must be a Standard 1 Year member to access this content.
Goodwin advised FNZ Group on the deal. FNZ Group (“FNZ”) announced its agreement to acquire International Fund Services & Asset Management S.A (“IFSAM”). The acquisition, which is...
You must be a Standard 1 Year member to access this content.
Goodwin advised the joint underwriters on the deal. NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading manufacturers and designers of high-tech electronic security devices,...
You must be a Standard 1 Year member to access this content.
CMS and Goodwin advised Pinova on the deal. Funds advised by Pinova Capital, an independent private equity firm focusing on high-growth SMEs, have acquired Riepe GmbH...
You must be a Standard 1 Year member to access this content.
Goodwin advised OKRA.ai on the deal. Bird & Bird and Ropes & Gray advised Envision Pharma Group. OKRA.ai announced their acquisition by Envision Pharma Group (Envision). Envision...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bessemer Venture Partners on the deal. Bessemer Venture Partners announced its acquisition of a majority stake in Litify. Bessemer partner Brian Feinstein will serve...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Globus Medical on the deal. Globus Medical (NYSE: GMED) announced its definitive agreement with NUVASIVE (NASDAQ: NUVA) to combine in an all-stock transaction. Under...
You must be a Standard 1 Year member to access this content.
